Lifestyle imagery of a man and woman hiking with forestry in the background.

Designed with your goals in mind

LEROCHOL is a treatment that lowers your LDL-C and fits into your life, not the other way around.

There’s a difference when it comes to LEROCHOL

Autoinjector
coming soon
LEROCHOL packaging and pre-filled syringe
  • Proven to significantly lower bad cholesterol up to 60%
  • Single, once-monthly, self-administered injection
  • Extended room temperature storage for up to 3 months*

*If LEROCHOL is not refrigerated for more than 3 months, it must be discarded.

Current treatment guidelines from multiple medical societies, including the American Heart Association, recommend:

Lower LDL-C for longer is better

Depending on factors
like age, overall health,
and health history,
your recommended
LDL-C target may be:

<70 mg/dL

if you have a HIGH
CARDIOVASCULAR RISK

<55 mg/dL

if you have a VERY HIGH
CARDIOVASCULAR RISK

For patients with HeFH
and LDL-C of ≥100 mg/dL,
it may be recommended to
ADD A PCSK9i to your
treatment plan.*

MEDICAL SOCIETIES WHO HAVE ENDORSED TREATMENT GUIDELINES:

  • American Association of Cardiovascular
    and Pulmonary Rehabilitation
  • Association of Black Cardiologists
  • American College of Cardiology
  • American College of Preventive Medicine
  • American Diabetes Association
  • American Geriatrics Society
  • American Heart Association
  • American Pharmacists Association
  • American Society for Preventive Cardiology
  • National Lipid Association
  • Preventive Cardiovascular Nurses Association
White icon of 2 silhouettes sitting at a desk Talk to your doctor about your LDL-C and whether it's at recommended target.

*For those on a maximally tolerated statin, the addition of ezetimibe, PCSK9 inhibitor and/or bempedoic acid is recommended. HeFH, heterozygous familial hypercholesterolemia; LDL-C, low-density lipoprotein cholesterol; mAb, monoclonal antibody, PCSK9i, proprotein convertase subtilisin/kexin type 9 inhibitor.

IMPORTANT SAFETY INFORMATION

DO NOT USE LEROCHOL® if you are allergic to lerodalcibep or to any of the ingredients in LEROCHOL.

What is LEROCHOL?

LEROCHOL is a prescription injectable medicine used along with diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad cholesterol,” in adults with hypercholesterolemia (high cholesterol), including heterozygous familial hypercholesterolemia (HeFH). It is not known if LEROCHOL is safe and effective in children.

Before using LEROCHOL

Before starting LEROCHOL, tell your healthcare provider, including your pharmacist, about all your medical conditions, including if you are pregnant or plan to become pregnant, are breastfeeding or plan to breastfeed, or if you take other medicines, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Using LEROCHOL

Use LEROCHOL exactly as your healthcare provider tells you to use it. LEROCHOL is a subcutaneous injection (under the skin) self-administered one time every month. If your healthcare provider decides that you or a caregiver can give the injections, you should receive training on the proper injection technique. Do not stop using LEROCHOL without talking to your healthcare provider, as cholesterol levels may increase if treatment is stopped.

What are the possible side effects of LEROCHOL?

The most common side effects of LEROCHOL include injection site reactions such as redness, itching, swelling, pain, bruising, or tenderness, runny or stuffy nose and sore throat (nasopharyngitis), diarrhea, nausea, and swelling of the arms, hands, legs, or feet (peripheral edema). These are not all the possible side effects of LEROCHOL. Tell your healthcare provider if you have any side effect that bothers you or does not go away.

Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs. Contact us at 1‑877‑2‑LEROCHOL (1‑877‑253‑7624) or the FDA by visiting www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.

You are about to leave the LEROCHOL.com website and enter a website operated by a third party.
LIB Therapeutics is not responsible for and does not endorse or control the content contained
on this third-party website.

By clicking “Continue” below, you acknowledge that you have read and reviewed
the information contained within the Notice of Third-Party Site.

Continue

The information on this site is intended for US healthcare professionals only.

Yes